Ardsley Advisory Partners LP Novartis Ag Transaction History

Ardsley Advisory Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $706,700 - $990,100	-10,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $843,500 - $953,700	10,000 New	10,000 $947,000
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $678,600 - $835,200	-9,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $150,640 - $172,300	2,000 Added 28.57%	9,000 $865,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $515,620 - $574,140	7,000 New	7,000 $601,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $296,560 - $309,080	-4,000 Closed	0 $0
Q2 2017 Sep 21, 2017	BUY	N/A	4,000	4,000 $334,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.